Healthspan Economy

The Atlas / Trials

Trials aimed at ageing

Interventional trials whose registered aim or primary outcome is ageing, healthspan, biological age or an ageing-related composite. Each record copies the registry entry as it stood on the date the Atlas read it, so the status and dates can have moved since. Results are shown only as posted or not posted, with the registry link; the Atlas does not summarize findings and does not say what works. Trials of a disease that merely enrol older people are left out. 38 trials recorded, 1 with results posted on the registry.

Recruiting8

Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial

TRIIM Treatment; Active Control

NCT04375657 Intervene Immune, Inc. Phase 2
Est. completion December 2025

Pilot Study on Evaluating the Geroprotective Effect of Metformin

Metformin Hydrochloride tablet; Placebo

NCT06459310 Xuanwu Hospital, Beijing Phase 2
Est. completion 31 July 2028

Intervention of Nicotinamide Mononucleotide in Middle-aged and Elderly People

NMN; placebo

NCT06592859 People's Hospital of Quzhou Not applicable
Est. completion 31 December 2026

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

Metformin; semaglutide; Anti-hypertensives; Lipid Lowering Medication; Life style intervention; Fezolinetant; Hormonal therapy

NCT06975111 University of Colorado, Denver Phase 2, Phase 3
Est. completion 1 October 2030

Tirzepatide to Slow Biological Aging

Zepbound

NCT07220473 The University of Texas Medical Branch, Galveston Phase 2
Est. completion January 2028

Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity

Semaglutide; Tirzepatide; Metformin

NCT07293325 Second Affiliated Hospital, Zhejiang University, School of Medicine Not applicable
Est. completion 2 June 2027

Project SIRT6 Activator

Fucoidan; Placebo

NCT07500649 National University of Singapore Not applicable
Est. completion 31 December 2027
Est. completion 1 December 2027

Enrolling by invitation3

Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV

Tirzepatide

NCT07707778 National Taiwan University Clinical Trial Center Phase 4
Est. completion December 2027

Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging Clocks

Topical anti-aging peptide serum

NCT07888595 Frontiers in Bioscience Research Institute and Aging Early Phase 1
Est. completion 14 October 2028

Tirzepatide and Organ-specific Biological Aging

Tirzepatide

NCT07906041 Atria Research and Global Health Institute (ARGHI) Phase 2
Est. completion September 2028

Not yet recruiting2

Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life

Psilocybin (Usona Institute)

NCT07719088 Charles Raison Phase 1
Est. completion December 2028

Validation & Intervention Testing for Aging, Longevity and Healthspan

Dapagliflozin 10Mg Oral Tablet; Semaglutide oral; Placebo

NCT07923630 The University of Texas Health Science Center at San Antonio Phase 2
Est. completion February 2031

Active, not recruiting4

An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer

Dasatinib plus Quercetin; Fisetin

NCT04733534 St. Jude Children's Research Hospital Phase 2
Est. completion December 2027

Does Alpha-ketoglutarate Supplementation Lower BiologicaL agE in Middle- Aged Adults?

Ca-AKG

NCT05706389 National University of Singapore Phase 2
Est. completion 15 January 2027

A Pilot Study on Reverse Aging (The REVERSE Study)

Rapamycin (Tablets); Prolon diet

NCT07354620 The Christ Hospital Early Phase 1
Est. completion May 2026

Biological Age Study of Chicken Essence

Essence of Chicken (BEC); Placebo

NCT07879742 Brand's Suntory Asia Not applicable
Est. completion April 2027

Completed9

Topical-RAPA Use in Inflammation Reversal and Re-setting the Epigenetic Clock

Rapamycin Topical Ointment; Placebo

NCT04608448 The University of Texas Health Science Center at San Antonio Early Phase 1
Completed 15 April 2022

Everolimus Aging Study

Everolimus 0.5 MG once per day; Everolimus 5 MG once per week; Placebo once per day; Placebo once per week

NCT05835999 University of Wisconsin, Madison Phase 2
Completed 22 July 2026

Oral Supplementation With AM3, Hesperidin and Spermidine Supplementation on Immunity Response and Biological Age.

Inmunoferon; Placebo

NCT06249620 Industrial Farmacéutica Cantabria, S.A. Not applicable
Completed 1 October 2022
Completed 13 November 2025

Evaluation of the Efficacy of Calcium a -Ketoglutarate(AKG-Ca) in Improving Human Aging

Calcium-a-ketoglutarate; Placebo(starch)

NCT07114536 Shenzhen Hygieia Biotech Co., Ltd Not applicable
Completed 30 November 2025

Multi-Modal Longevity Protocol Including Autologous Cell-Free Conditioned Media

Multi-Modal Longevity Protocol

NCT07322224 BlueBird Age Reversal SA Not applicable
Completed 20 March 2025

Combination Gerotherapeutic Interventions for Healthspan Improvement

Rapamycin; Naltrexone; Metformin; NAD+; GSH; Infinite Supplement; Placebo/control; B12

NCT07475546 AgelessRx Phase 3
Completed 9 April 2026

The Impact of Exercise Intervention on Biological and Functional Aging Through the Lens of Epigenetic Clocks

Exercise - Relative High-Intensity Interval Training (HIIT)

NCT07799103 Hungarian University of Sports Science Not applicable
Completed 30 June 2024

Unknown status11

Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects

Plasma Transfusion

NCT03353597 Chandra Duggirala Phase 1, Phase 2
Est. completion 15 December 2022

Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old

plasma exchange with albumin; plasma exchange without albumin

NCT04897113 National Medical Research Center for Rehabilitation and Balneology Not applicable
Est. completion 30 December 2022

Safety and Effectivness of Quercetin & Dasatinib on Epigenetic Aging

Dasatinib plus Quercetin

NCT04946383 TruDiagnostic Phase 2
Est. completion 30 June 2022

Ketamine and Epigenetic Aging

Ketamine

NCT05294835 TruDiagnostic Phase 2
Est. completion 31 December 2022

Safety & Efficacy of Extended Longevity Protocol

Extracts found in the Extended Longevity supplements

NCT05296993 TruDiagnostic Phase 2
Est. completion December 2023

A Dosing Study of Hyperbaric Oxygen Therapy (HBOT) on Epigenetic Aging

Hyperbaric Oxygen Therapy

NCT05297019 TruDiagnostic Phase 2, Phase 3
Est. completion 1 July 2023

The Impact of a Human Breast Milk Supplement on Epigenetic and Cellular Markers

Trulacta breastmilk supplement

NCT05297097 TruDiagnostic Phase 2
Est. completion 30 December 2022

AC-11 Supplement and Biological Aging

AC-11

NCT05310123 TruDiagnostic Phase 2
Est. completion October 2022

Cocoa Supplementation, Inflammaging, and Epigenetic Aging

Cocoa extract; Multivitamin; Cocoa extract placebo; Multivitamin placebo

NCT05510375 Augusta University Phase 4
Est. completion 30 September 2023

Targeting the Nine Hallmarks of Aging on DNA Methylation

SRW Cel System

NCT05535608 TruDiagnostic Phase 2
Est. completion 31 December 2023

Effect of Bifidobacterium Adolescentis on Aging in Healthy Adults (45-65 Years)

Bifidobacterium adolescentis; Placebo

NCT05603455 Second Affiliated Hospital, Zhejiang University, School of Medicine Not applicable
Est. completion 31 December 2024

Withdrawn1

VIAging Deceleration Trial Using Metformin, Dasatinib, Rapamycin and Nutritional Supplements

Study Drugs and Nutritional Supplements

NCT04994561 Vitality in Aging Research Group, Inc. Phase 1
Est. completion December 2023